According to the authors.

According to the authors, FPHL affects up to 50% of women during their life, can be a origination of trouble and social psychological condition, and if untreated, may rapidly advancement. Ternion different patterns of FPHL have been identified: Christmastime tree, Ludwig, and the Alice Hamilton blueprint. Topical minoxidil is currently an approved communicating but may not be well accepted by women. Finasteride is a 5α-reductase type II inhibitor currently approved for male androgenetic alopecia at a medicament of 1 mg/day but is contraindicated in women of childbearing electrical phenomenon because of teratogenic effects. According to the authors, studies of finasteride at 1 mg/day have shown little essence on hair emergence patterns for women with FPHL, and a higher dose may be needed for women.


The course visitation is an open descriptive field of a higher dose of finasteride (2.5 mg daily) combined with oral contraceptives to examine its import on FPHL. There was no medicine abstract entity. An oral contraceptive containing drospirenone and ethinyl estradiol was selected because of its antiandrogenic act and opening adjuvant upshot on finasteride.